(a) (i) Describe the challenges of circulating Vaccine-Derived Poliovirus (VDPV). Add a note on the environmental surveillance and preventive strategies for effective maintenance of Polio elimination. 10 marks

(ii) Describe the mode of infection and

Question

(a) (i) Describe the challenges of circulating Vaccine-Derived Poliovirus (VDPV). Add a note on the environmental surveillance and preventive strategies for effective maintenance of Polio elimination. 10 marks

(ii) Describe the mode of infection and clinical manifestation of cryptococcosis. Discuss the role of the rapid diagnostic test in comparison to conventional techniques for identifying the infection. 10 marks

(b) (i) Define 'Injury', 'Hurt' and 'Grievous Hurt'. Add a note on the medicolegal aspects of contusion. 10 marks

(ii) Describe the various tests prescribed for blood and seminal stains obtained during the examination of a victim of rape and their role in the investigation. 10 marks

(c) (i) Enumerate the drugs used in the management of hypertensive crisis. Also describe the route of administration and their side effects. 5 marks

(ii) Name the drugs, doses and duration of treatment after post-exposure prophylaxis of HIV. 5 marks

UPSC Answer Check · Accepted Answer

The directive 'describe' demands comprehensive, structured exposition across all six sub-parts. Allocate approximately 35% time/words to (a)(i)-(ii) combined (Microbiology, 20 marks), 35% to (b)(i)-(ii) combined (Forensic Medicine, 20 marks), and 30% to (c)(i)-(ii) combined (Pharmacology, 10 marks). Structure each sub-part with clear headings: definition/epidemiology → pathogenesis/mechanism → clinical features → diagnosis/investigation → management/prevention. Use bullet points for drug names, doses, and legal sections to enhance examiner readability.
- For (a)(i): VDPV emergence via OPV reversion in under-immunized communities; distinction between cVDPV, iVDPV, and aVDPV; environmental surveillance via sewage sampling (AFP + environmental surveillance model); preventive strategies including IPV introduction, outbreak response with mOPV/bOPV, and maintenance of 90%+ routine immunization coverage
- For (a)(ii): Cryptococcus neoformans/gattii inhalation from pigeon/bird droppings; immunocompromised host (HIV CD4<100); meningoencephalitis presentation with 'soap-bubble' lesions; India ink, cryptococcal antigen (CrAg) in serum/CSF (LFA/ELISA) vs culture/histopathology; rapid diagnostic advantage in resource-limited settings
- For (b)(i): Section 44 IPC definition of 'Injury' (any harm illegally caused); Section 319 IPC 'Hurt' (bodily pain, disease, infirmity); Section 320 IPC 'Grievous Hurt' (8 clauses: emasculation, permanent privation of sight/hearing, privation of joint, permanent disfiguration, fracture, tooth, endangering life, severe bodily pain for 20 days); contusion medicolegal aspects: pattern matching weapon, age estimation by color changes, differentiation from post-mortem lividity
- For (b)(ii): Blood stains: benzidine test (presumptive), Takayama test (confirmatory), species origin by precipitin test, blood grouping; Seminal stains: Florence test (choline crystals), acid phosphatase test, microscopic examination for spermatozoa, DNA profiling; role in establishing sexual assault, identifying perpetrator through DNA, corroborating victim testimony
- For (c)(i): Hypertensive crisis drugs: sodium nitroprusside (IV infusion, cyanide toxicity), labetalol (IV bolus/infusion, bronchospasm), nicardipine (IV infusion, reflex tachycardia), esmolol (IV, ultra-short acting), hydralazine (IM/IV, reflex tachycardia), nitroglycerin (IV, headache/tolerance); oral options: nifedipine, captopril for less severe cases
- For (c)(ii): HIV PEP: tenofovir 300mg + emtricitabine 200mg (or lamivudine 300mg) + raltegravir 400mg BD (or dolutegravir 50mg OD) for 28 days; alternative: lopinavir/ritonavir; initiation within 72 hours of exposure; baseline and follow-up HIV testing at 6 weeks, 3 months, 6 months

Dimension	Weight	Max marks	Excellent	Average	Poor
Concept correctness	20%	10	Accurately defines all legal terms per IPC sections (44, 319, 320); correctly classifies VDPV types and their reversion mechanisms; precisely states HIV PEP drug combinations, doses, and 28-day duration; no factual errors in pharmacological mechanisms or forensic definitions	Minor errors in IPC section numbers or drug dosages; incomplete VDPV classification; conflates hypertensive urgency with emergency; generally correct but lacks precision in terminology	Major conceptual errors such as confusing VDPV with wild poliovirus, wrong legal definitions (e.g., equating hurt with grievous hurt), incorrect HIV PEP regimen (omitting integrase inhibitor), or fundamental misunderstanding of diagnostic test principles
Clinical correlation	20%	10	Links cryptococcal meningitis to HIV/AIDS epidemiology in India; connects contusion patterns to weapon identification in forensic casework; relates hypertensive crisis drugs to specific clinical scenarios (aortic dissection vs. pregnancy); cites Indian public health context (pulse polio, NACO guidelines)	Generic clinical correlations without Indian context; mentions AIDS as risk factor but not CD4 count specifics; states drug indications without scenario-based application; limited integration of laboratory findings with clinical presentation	No clinical correlation attempted; isolated facts without disease-context linkage; fails to mention immunocompromised status for cryptococcosis or emergency vs. urgency distinction in hypertension management
Diagram / pathway	20%	10	Includes labeled diagram of contusion color changes over time for age estimation; flowchart for VDPV surveillance and response algorithm; schematic of cryptococcal diagnostic algorithm comparing conventional vs. rapid tests; table format for drug comparisons enhances clarity	Mentions diagrams but not drawn or poorly labeled; uses tables for drug lists but without comparative columns; describes pathways in text without visual representation; adequate organization but lacks visual impact	No diagrams, tables, or flowcharts; dense paragraph format for all information; no attempt to visually represent diagnostic algorithms, legal distinctions, or treatment pathways; poor structural organization
Differential / staging	20%	10	Differentiates cVDPV vs. iVDPV vs. aVDPV with epidemiological criteria; distinguishes contusion from post-mortem lividity and antemortem bruising; contrasts presumptive vs. confirmatory forensic tests with specificity/sensitivity data; differentiates hypertensive emergency from urgency with end-organ damage criteria	Basic differentiation without detailed criteria; mentions VDPV types but not transmission patterns; states hurt vs. grievous hurt differences without citing IPC clauses; limited comparison of diagnostic test characteristics	No differential diagnosis or staging attempted; fails to distinguish between similar entities (e.g., VDPV and wild polio, contusion and abrasion); omits comparative analysis entirely; confuses categories fundamentally
Management / public-health angle	20%	10	Comprehensive preventive strategy for polio: IPV transition, outbreak response protocols, environmental surveillance expansion per India-UNICEF model; detailed HIV PEP protocol with adherence counseling; forensic evidence chain of custody and court presentation; includes WHO/CDC/NACO guidelines with Indian program specifics	Generic management statements without specific protocols; mentions pulse polio without current IPV strategy; states drug names without dosing or monitoring; basic forensic evidence collection without chain of custody details; limited public health integration	No preventive or public health perspective; omits surveillance strategies entirely; no mention of national programs (NPEP, NACP); fails to address drug side effect monitoring or medicolegal evidence preservation; purely descriptive without application focus

Q8

Directive word: Describe

How this answer will be evaluated

Approach

Key points expected

Evaluation rubric

Practice this exact question

More from Medical Science 2025 Paper I